This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about Ceramide synthase 2.
.
Human | |
---|---|
Gene Name: | CERS2 |
Uniprot: | Q96G23 |
Entrez: | 29956 |
Belongs to: |
---|
No superfamily |
ceramide synthase 2; CerS2; LAG1 homolog, ceramide synthase 2; LAG1 longevity assurance 2; LAG1 longevity assurance homolog 2 (S. cerevisiae); LAG1 longevity assurance homolog 2; S. cerevisiae) homolog 2; SP260MGC987; TMSG1; Tumor metastasis-suppressor gene 1 protein
Mass (kDA):
44.876 kDA
Human | |
---|---|
Location: | 1q21.3 |
Sequence: | 1; NC_000001.11 (150965173..150975003, complement) |
Expressed in kidney, liver, brain, heart, placenta and lung.
Endoplasmic reticulum membrane; Multi-pass membrane protein.
In this article, I'll talk about the Boster Bio, the aGalCer, and ArtGSLs. Steven Boster will also get a mention. These methods are great tools to optimize your experiments. This article should have helped you make the best decisions for your research. If not, please visit my website. I will answer any questions you may have about Boster Bio.
If you're planning to use CERS2 in your experiments, it is important that you understand the flow procedures. The flow procedures offer many options. Boster Bio optimization guide can help you if you have questions about any flow procedure. They will help to determine the ideal conditions for your experiment. The CERS2 protein is a recombinant, cytoplasmic marker that is found in cells.
The CERS2 genome encodes a protein that synthesizes very-long chain ceramides. These fatty acids interfere with matrix metaloproteinases and inhibit cell invasion and metastasis. The gene is identified by an 8th exon that contains the entire Lag1p molecular sequence. This motif confers CERS2 protein acyl-chain substrate specificity. The TLC catalytic domain contains the TRAM, Lag1p and CLN8 (TD) sequences.
The CERS2 Marker, a highly selective antibody that can detect a wide range biological materials, is very useful. It is highly immunoreactive to a variety proteins, including human protein and mouse protein. Boster antibodies have long been in use and are highly regarded by researchers. Boster antibodies have been validated using Western Blotting, Immunohistochemistry, and ELISA techniques.
ArtGSLs can induce a specific adaptive immune response by stimulating the production of antibodies against Oligosaccharides. Additionally, conjugates can produce a variety antibodies that are reactive to oligosaccharides. This feature could be used for vaccines that target aberrant glycosylation in certain cancers. It also allows scientists target anti-glycoconjugate immune responses against cancer-associated carbohydrates antigens.
A recent study found that artGSLs with non-reducing terminal mennose significantly increased IgG inducing activity in mice. These artGSLs were more effective that those containing nonreducing terminus mannose. Six of nine mice had IgG levels over five times that of the median background value. CERS2 is a marker that is extremely specific and can be used for testing the anti immuneogen of choice.
The CERS2 marker is one the most powerful tools historians and genealogists have to locate and commemorate historical persons and places. Steven Boster's name is also a testament to his legacy of service to his community. He served for many years in the U.S. Army. He was also a Concordia Hall, Staunton, Virginia member. Steve Boster's final words reflect his deep love for the outdoors and the mountains of West Virginia.
PMID: 11543633 by Pan H., et al. Cloning, mapping, and characterization of a human homologue of the yeast longevity assurance gene LAG1.
PMID: 16263699 by Lewandrowski U., et al. Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach.